➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: July 31, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for BENZOTHIAZOLE

Email this page to a colleague

« Back to Dashboard

What is the drug development status for BENZOTHIAZOLE?

BENZOTHIAZOLE is an investigational drug.

There have been 3 clinical trials for BENZOTHIAZOLE. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2017.

The most common disease conditions in clinical trials are Spinal Cord Injuries, Renal Insufficiency, and Spinocerebellar Degenerations. The leading clinical trial sponsors are Rick Hansen Institute, Christopher Reeve Paralysis Foundation, and AOSpine International.

Recent Clinical Trials for BENZOTHIAZOLE
Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL)Assistance Publique - Hôpitaux de ParisPhase 3
Riluzole in Spinal Cord Injury StudyAOSpine InternationalPhase 2/Phase 3
Riluzole in Spinal Cord Injury StudyChristopher Reeve Paralysis FoundationPhase 2/Phase 3

See all BENZOTHIAZOLE clinical trials

Clinical Trial Summary for BENZOTHIAZOLE

Top disease conditions for BENZOTHIAZOLE
Top clinical trial sponsors for BENZOTHIAZOLE

See all BENZOTHIAZOLE clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.